Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals (Q40761226)

23 September 2017

Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals (English)

1 reference

23 September 2017

0 references

0 references

1 reference

11

1 reference

23 September 2017

Simona Vertuani

1

1 reference

23 September 2017

Martina Bazzaro

2

1 reference

23 September 2017

Guido Gualandi

3

1 reference

23 September 2017

Fabiola Micheletti

4

1 reference

23 September 2017

Mauro Marastoni

5

1 reference

23 September 2017

Cinzia Fortini

6

1 reference

23 September 2017

Alessandro Canella

7

1 reference

23 September 2017

Michele Marino

8

1 reference

23 September 2017

Roberto Tomatis

9

1 reference

23 September 2017

Serena Traniello

10

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

European Journal of Immunology

23 September 2017

1 reference

23 September 2017

32

1 reference

23 September 2017

1

1 reference

23 September 2017

144-154

1 reference

Immunopathogenesis of hepatitis C virus infection

23 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

The function of type I interferons in antimicrobial immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Degradation of cell proteins and the generation of MHC class I-presented peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Peptide-induced antiviral protection by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Supra-agonist peptides enhance the reactivation of memory CTL responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X

10.1002/1521-4141(200201)32:1<144::AID-IMMU144>3.0.CO;2-X

21 January 2018

Identifiers

DOI

1 reference

release_2aabitdybfcsrmjw3pyutydezq

23 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2aabitdybfcsrmjw3pyutydezq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference